101 related articles for article (PubMed ID: 20452759)
1. Dynamic hyperinflation after metronome-paced hyperventilation in COPD--a 2 year follow-up.
Hannink J; Lahaije A; Bischoff E; van Helvoort H; Dekhuijzen R; Schermer T; Heijdra Y
Respir Med; 2010 Nov; 104(11):1700-5. PubMed ID: 20452759
[TBL] [Abstract][Full Text] [Related]
2. Effects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with COPD.
Fujimoto K; Yoshiike F; Yasuo M; Kitaguchi Y; Urushihata K; Kubo K; Honda T
Respirology; 2007 Jan; 12(1):93-9. PubMed ID: 17207032
[TBL] [Abstract][Full Text] [Related]
3. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
4. Tiotropium and simplified detection of dynamic hyperinflation.
Gelb AF; Taylor CF; McClean PA; Shinar CM; Rodrigues MT; Gutierrez CA; Chapman KR; Zamel N
Chest; 2007 Mar; 131(3):690-695. PubMed ID: 17356081
[TBL] [Abstract][Full Text] [Related]
5. Lack of protective effect of tiotropium vs induced dynamic hyperinflation in moderate COPD.
Gelb AF; Fraser C; Zamel N
Respir Med; 2011 May; 105(5):755-60. PubMed ID: 21159499
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium induced bronchodilation and protection from dynamic hyperinflation is independent of extent of emphysema in COPD.
Gelb AF; Taylor CF; Cassino C; Shinar CM; Schein MJ; Zamel N
Pulm Pharmacol Ther; 2009 Jun; 22(3):237-42. PubMed ID: 19138754
[TBL] [Abstract][Full Text] [Related]
7. Simplified detection of dynamic hyperinflation.
Gelb AF; Gutierrez CA; Weisman IM; Newsom R; Taylor CF; Zamel N
Chest; 2004 Dec; 126(6):1855-60. PubMed ID: 15596684
[TBL] [Abstract][Full Text] [Related]
8. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators.
Kitaguchi Y; Fujimoto K; Komatsu Y; Hanaoka M; Honda T; Kubo K
Respir Med; 2013 Mar; 107(3):394-400. PubMed ID: 23245993
[TBL] [Abstract][Full Text] [Related]
9. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
10. Time course and degree of hyperinflation with metronome-paced tachypnea in COPD patients.
Weigt SS; Abrazado M; Kleerup EC; Tashkin DP; Cooper CB
COPD; 2008 Oct; 5(5):298-304. PubMed ID: 18972278
[TBL] [Abstract][Full Text] [Related]
11. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD.
O'Donnell DE; Casaburi R; Vincken W; Puente-Maestu L; Swales J; Lawrence D; Kramer B;
Respir Med; 2011 Jul; 105(7):1030-6. PubMed ID: 21498063
[TBL] [Abstract][Full Text] [Related]
12. Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD.
Maltais F; Celli B; Casaburi R; Porszasz J; Jarreta D; Seoane B; Caracta C
Respir Med; 2011 Apr; 105(4):580-7. PubMed ID: 21183326
[TBL] [Abstract][Full Text] [Related]
13. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).
Morice AH; Celli B; Kesten S; Lystig T; Tashkin D; Decramer M
Respir Med; 2010 Nov; 104(11):1659-67. PubMed ID: 20724131
[TBL] [Abstract][Full Text] [Related]
14. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
16. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
17. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of metronome-paced tachypnea to detect dynamic hyperinflation.
Lahaije AJ; Willems LM; van Hees HW; Dekhuijzen PN; van Helvoort HA; Heijdra YF
Clin Physiol Funct Imaging; 2013 Jan; 33(1):62-9. PubMed ID: 23216767
[TBL] [Abstract][Full Text] [Related]
19. Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD.
Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
Respir Physiol Neurobiol; 2010 Aug; 173(1):58-63. PubMed ID: 20601207
[TBL] [Abstract][Full Text] [Related]
20. Determinants of dynamic hyperinflation during metronome-paced tachypnea in COPD and normal subjects.
Cooper CB; Calligaro GL; Quinn MM; Eshaghian P; Coskun F; Abrazado M; Bateman ED; Raine RI
Respir Physiol Neurobiol; 2014 Jan; 190():76-80. PubMed ID: 23994176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
